{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:52:24Z","timestamp":1771512744008,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,25]]},"DOI":"10.7759\/cureus.32943","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T07:11:01Z","timestamp":1672038661000},"source":"Crossref","is-referenced-by-count":1,"title":["Ibrutinib-Induced Paronychia and Periungual Pyogenic Granuloma"],"prefix":"10.7759","author":[{"given":"Awadh","family":"Alamri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atheer","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhai B","family":"Albogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Shahada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aseel","family":"AlHarbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2008.02799.x","article-title":"Subungueal pyogenic granuloma secondary to docetaxel therapy","volume":"34","author":"Devillers C","year":"2009","unstructured":"Devillers C, Vanhooteghem O, Henrijean A, Ramaut M, de la Brassinne M. Subungueal pyogenic granuloma secondary to docetaxel therapy. Clin Exp Dermatol. 2009, 34:251-2. 10.1111\/j.1365-2230.2008.02799.x","journal-title":"Clin Exp Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.02.001","article-title":"Management of adverse effects\/toxicity of ibrutinib","volume":"136","author":"Paydas S","year":"2019","unstructured":"Paydas S. Management of adverse effects\/toxicity of ibrutinib. Crit Rev Oncol Hematol. 2019, 136:56-63. 10.1016\/j.critrevonc.2019.02.001","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.720704","article-title":"Monitoring and managing BTK inhibitor treatment-related adverse events in clinical practice","volume":"11","author":"O'Brien SM","year":"2021","unstructured":"O'Brien SM, Brown JR, Byrd JC, Furman RR, Ghia P, Sharman JP, Wierda WG. Monitoring and managing BTK inhibitor treatment-related adverse events in clinical practice. Front Oncol. 2021, 11:720704. 10.3389\/fonc.2021.720704","journal-title":"Front Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40800-017-0060-1","article-title":"Ibrutinib-associated nail plate abnormalities: case reports and review","volume":"4","author":"Heldt Manica LA","year":"2017","unstructured":"Heldt Manica LA, Cohen PR. Ibrutinib-associated nail plate abnormalities: case reports and review. Drug Saf Case Rep. 2017, 4:15. 10.1007\/s40800-017-0060-1","journal-title":"Drug Saf Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000502986","article-title":"Paronychia and periungual granulation as a novel side effect of ibrutinib: a case report","volume":"6","author":"Yorulmaz A","year":"2020","unstructured":"Yorulmaz A, Yalcin B. Paronychia and periungual granulation as a novel side effect of ibrutinib: a case report. Skin Appendage Disord. 2020, 6:32-6. 10.1159\/000502986","journal-title":"Skin Appendage Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/OP.20.00037","article-title":"Pyogenic granuloma during ibrutinib therapy for B-cell neoplasia","volume":"16","author":"Roussel X","year":"2020","unstructured":"Roussel X, Charollais R, Deconinck E, Daguindau E, Brion A. Pyogenic granuloma during ibrutinib therapy for B-cell neoplasia. JCO Oncol Pract. 2020, 16:834-6. 10.1200\/OP.20.00037","journal-title":"JCO Oncol Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.0225","article-title":"Hair and nail changes during long-term therapy with ibrutinib for chronic lymphocytic leukemia","volume":"152","author":"Bitar C","year":"2016","unstructured":"Bitar C, Farooqui MZ, Valdez J, et al.. Hair and nail changes during long-term therapy with ibrutinib for chronic lymphocytic leukemia. JAMA Dermatol. 2016, 152:698-701. 10.1001\/jamadermatol.2016.0225","journal-title":"JAMA Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1986.tb00439.x","article-title":"Etretinate and the nails (study of 130 cases) possible mechanisms of some side-effects","volume":"11","author":"Baran R","year":"1986","unstructured":"Baran R. Etretinate and the nails (study of 130 cases) possible mechanisms of some side-effects. Clin Exp Dermatol. 1986, 11:148-52. 10.1111\/j.1365-2230.1986.tb00439.x","journal-title":"Clin Exp Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128289-ibrutinib-induced-paronychia-and-periungual-pyogenic-granuloma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:12Z","timestamp":1707508032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128289-ibrutinib-induced-paronychia-and-periungual-pyogenic-granuloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,25]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.32943","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,25]]}}}